Vicky Mai

[ThoraxBMJ @ThoraxBMJ]

Patients’ perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy https://t.co/2cud1FZkJN

[Marc Carrier @MarcCarrier1]

Dr. @camillemsimard reporting the risk of bleeding in pregnant patients with acute VTE. 7.7% of women experience bleeding requiring hospitalization. Seems high for VTE but not that different of cohorts reporting bleeding rates in the general pregnancy population. #ASH22 🤰

[Camille Simard @camillemsimard]

Looking forward to ⁦@isth à Montréal! #ISTH2023 #ASH2022 ⁦@canvector⁩ ⁦@SusanRKahn1⁩ ⁦@RodgerMarc⁩

[Vicky Mai @Vicky_Mai_]

@daniellle_roy from @UottawamedG reporting that Factor V Leiden and ABO gene mutations are important predictors of cancer-associated thrombosis at #ASH2022 @ThrombosisCan @canvector @INVENT_VTE 🎉

[Vicky Mai @Vicky_Mai_]

Thank you very much @MahaOthman8 for taking the time to come and give us this inspirational talk 🙌

[Professor Maha Othman @MahaOthman8]

Enjoyed my talk at PhD Seminar Series @uOttawa & chats with a group of bright post Grads!

🙏🙏@Vicky_Mai_for the kind invitation.

🙏🙏 @grelegal for making time in your super busy schedule to give me a tour at the Thrombosis Unit. Great meeting lovely colleagues in action😊

[Vicky Mai @Vicky_Mai_]

Honored to be one of the ISTH-INVENT Traning Fellowship Award recipients. Thank you very much @isth and @INVENT_VTE for this opportunity! 🙏

[ISTH @isth]

NEW: The ISTH has awarded 5 training fellowships to early career professionals. Join us in congratulating @gael_beverley, @gauer_s, @_sarahkelliher, @Vicky_Mai_, and Luuk Scheres! Two fellowships were awarded in partnership with @INVENT_VTE. https://t.co/JSZuipFlsy

[Lana Castellucci @LanaCastellucci]

@ the Toronto sign #WTDay22 @thrombosisday @ThrombosisCan @canvector @INVENT_VTE @isth

[Lana Castellucci @LanaCastellucci]

The Canadian crew at the CN tower Toronto on #WTDay22 @thrombosisday @ThrombosisCan @canvector @INVENT_VTE @isth

[Tzu-Fei Wang @TzufeiWang]

The new SSC guidance document hopes to provide practical guidance for the management of antithrombotic agents or thrombocytopenia for common #cancer procedures @jzbos @KSanfilippoMD @JTHjournal
https://t.co/QdQQTA9j8l

[American Thoracic Society (ATS) @atscommunity]

Home oxygen probably makes no difference to the 3-year death rate among patients with #COPD and moderate hypoxemia: https://t.co/1XLzmKCJn4

[Miguel García @MiguelG_pds]

Amazing work from @uoftmedicine students at #WCLC2022
Jae Lee on osimertinib outcomes in real world, similar to FLAURA. Tedi Hoxha shows that less than 50% of pts received adjuvant chemo in our real world dataset. Allison Moore found worse survival in EGFRm NSCLC & co-mutations

[Jason Weatherald MD @AlbertaPHdoc]

Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials https://t.co/sKsx9fYC4L

Honoured to be a part of this work out of @IUCPQ
@sbonnet2 @Vicky_Mai_